This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Gilead Sciences, Inc.
Drug Names(s): GS-9256
Description: GS 9256 is an NS3 protease inhibitor in development for Hepatitis C.
GS 9256 News
Additional information available to subscribers only: